Skip to main content
. 2021 Feb 13;11(2):109. doi: 10.3390/metabo11020109

Figure 1.

Figure 1

Schematic representation of in vivo 1H-MRS study design for orthotopic glioma-bearing mouse models treated with mutant IDH inhibitors.